PetIQ Inc (PETQ)
19.76
+0.19
(+0.97%)
USD |
NASDAQ |
May 15, 14:21
PetIQ Free Cash Flow: 11.28M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | 11.28M |
December 31, 2023 | 52.74M |
September 30, 2023 | 105.24M |
June 30, 2023 | 119.74M |
March 31, 2023 | 41.87M |
December 31, 2022 | 36.05M |
September 30, 2022 | -4.06M |
June 30, 2022 | -16.42M |
March 31, 2022 | 7.117M |
December 31, 2021 | -7.503M |
September 30, 2021 | 57.96M |
June 30, 2021 | -38.56M |
March 31, 2021 | -18.99M |
December 31, 2020 | -26.99M |
September 30, 2020 | -74.78M |
Date | Value |
---|---|
June 30, 2020 | -22.58M |
March 31, 2020 | -44.03M |
December 31, 2019 | 10.56M |
September 30, 2019 | -13.85M |
June 30, 2019 | -25.80M |
March 31, 2019 | 1.968M |
December 31, 2018 | -19.59M |
September 30, 2018 | -25.13M |
June 30, 2018 | -4.158M |
March 31, 2018 | -21.53M |
December 31, 2017 | 1.751M |
September 30, 2017 | 7.381M |
June 30, 2017 | 2.176M |
March 31, 2017 | -15.99M |
December 31, 2016 | -2.967M |
Free Cash Flow Range, Past 5 Years
-74.78M
Minimum
Sep 2020
119.74M
Maximum
Jun 2023
7.450M
Average
-5.782M
Median
Free Cash Flow Benchmarks
Dynavax Technologies Corp | 52.69M |
Pacira BioSciences Inc | 173.19M |
Supernus Pharmaceuticals Inc | 99.84M |
Esperion Therapeutics Inc | -27.38M |
Deciphera Pharmaceuticals Inc | -152.39M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -85.14M |
Cash from Investing (Quarterly) | -0.822M |
Cash from Financing (Quarterly) | -5.074M |
Free Cash Flow Per Share (Quarterly) | -2.493 |
Free Cash Flow to Equity (Quarterly) | -84.76M |
Free Cash Flow to Firm (Quarterly) | -77.78M |
Free Cash Flow Yield | 1.84% |